ProShare Advisors LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$672,513
+54.7%
25,503
+0.9%
0.00%
+100.0%
Q2 2023$434,816
+14.2%
25,280
+10.1%
0.00%0.0%
Q1 2023$380,610
+92.2%
22,956
-11.7%
0.00%0.0%
Q4 2022$198,013
-17.1%
25,986
+8.3%
0.00%0.0%
Q3 2022$239,000
+5.3%
24,001
-4.1%
0.00%0.0%
Q2 2022$227,000
-40.4%
25,020
-33.5%
0.00%0.0%
Q1 2022$381,000
-51.0%
37,637
-19.2%
0.00%
-50.0%
Q4 2021$778,000
-65.7%
46,605
-3.7%
0.00%
-66.7%
Q3 2021$2,267,000
-32.1%
48,371
-11.6%
0.01%
-40.0%
Q2 2021$3,337,000
+18.0%
54,744
+19.2%
0.01%
+11.1%
Q1 2021$2,829,000
+13.5%
45,922
+31.0%
0.01%0.0%
Q4 2020$2,492,000
+131.8%
35,050
+22.4%
0.01%
+80.0%
Q3 2020$1,075,000
+12.6%
28,646
-2.2%
0.01%0.0%
Q2 2020$955,000
+53.8%
29,292
+36.9%
0.01%
+25.0%
Q1 2020$621,000
-40.5%
21,398
-28.2%
0.00%
-20.0%
Q4 2019$1,044,00029,7860.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders